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Edited by Alex TokerThe study of extracellular phosphorylation was initiated in
late 19th century when the secreted milk protein, casein, and
egg-yolk protein, phosvitin, were shown to be phosphorylated.
However, it took more than a century to identify Fam20C,
which phosphorylates both casein and phosvitin under physio-
logical conditions. This kinase, along with its family members
Fam20A and Fam20B, defined a new family with altered amino
acid sequences highly atypical from the canonical 540 kinases
comprising the kinome. Fam20B is a glycan kinase that phos-
phorylates xylose residues and triggers peptidoglycan biosyn-
thesis, a role conserved from sponges to human. The protein
kinase, Fam20C, conserved from nematodes to humans, phos-
phorylates well over 100 substrates in the secretory pathway
with overall functions postulated to encompass endoplasmic
reticulum homeostasis, nutrition, cardiac function, coagulation,
and biomineralization. The preferred phosphorylation motif of
Fam20C is SxE/pS, and structural studies revealed that related
member Fam20A allosterically activates Fam20C by forming a
heterodimeric/tetrameric complex. Fam20A, a pseudokinase, is
observed only in vertebrates. Loss-of-function genetic alter-
ations in the Fam20 family lead to human diseases such as
amelogenesis imperfecta, nephrocalcinosis, lethal and nonlethal
forms of Raine syndrome with major skeletal defects, and
altered phosphate homeostasis. Together, these three members
of the Fam20 family modulate a diverse network of secretory
pathway components playing crucial roles in health and disease.
The overarching theme of this review is to highlight the prog-
ress that has been made in the emerging field of extracellular
phosphorylation and the key roles secretory pathway kinases
play in an ever-expanding number of cellular processes.
The study of protein phosphorylation began as early as 1883
to 1900, when phosphorous was detected in milk casein (1)
and egg-yolk phosvitin (2) respectively, thus making them the
two earliest known phosphoproteins. Intriguingly, both these
phosphoproteins are secreted from cells. Casein is secreted in
milk (3) while phosvitin, a cleaved form of vitellogenin, is
synthesized in the liver and secreted into the oviduct (4, 5).
Since these initial discoveries, casein and phosvitin have been
used as common artificial substrates in the study of numerous* For correspondence: Jack E. Dixon, jedixon@ucsd.edu; Sourav
Banerjee, s.y.banerjee@dundee.ac.uk.
© 2021 THE AUTHORS. Published by Elsevier Inc on behalf of American Society for
BY license (http://creativecommons.org/licenses/by/4.0/).kinases (6–8). In fact, the first evidence for the existence of
protein kinases was provided by the pioneering study of
George Burnett and Eugene Kennedy where they used rat
mitochondrial extract to provide ATP and casein as the sub-
strate to demonstrate the covalent addition of phosphate to
casein in vitro (6). Since that time, many investigators have
added to the number and complexity of kinases leading to the
compilation of the kinome in 2002 (9). This list of the human
kinome included 540 individual members and represented
kinases that could phosphorylate proteins as well as other
biological molecules such as lipids and carbohydrates primarily
within the cytosol and nucleus of the cell. But what about the
kinases that phosphorylate resident proteins in the secretory
pathway or proteins destined for secretion? This question was
partially answered when the physiological secretory pathway
kinase phosphorylating casein, family of sequence similarity
20C (Fam20C), was discovered in 2012 (10, 11). This same
kinase was found to phosphorylate phosvitin in 2018 and
thereby is accountable for the phosphorylation of the first
identified secreted phosphoproteins (5).
The first clue for recognizing the secretory pathway kinases
came from the identification of the Drosophila protein, four-
jointed (Fj), as a secretory pathway kinase that phosphory-
lated the extracellular domains of atypical cadherins (12).
Using Fj as a BLAST query revealed a small family of related
proteins that included Fam20A, B, and C (11). Since little was
known about these proteins, they were designated “Fams”
based on shared but limited sequence similarity. They all
harbor a signal peptide that would direct them into the
secretory pathway, but due to a lack of sequence similarity
with canonical kinases, none of these atypical kinases were
represented in the human kinome. The other domain these
proteins share, which is also the sequence of highest homol-
ogy, is the C-terminal Fam20 domain. Unexpectedly, the
conserved Fam20 domain in each of these proteins has a very
different function. Fam20C is the Golgi casein kinase
responsible for phosphorylating secreted proteins on SxE/pS
motifs (11). Fam20A is a pseudokinase that interacts with
Fam20C and increases its activity (13), and Fam20B is a xylose
kinase involved in proteoglycan biosynthesis (14, 15).
Over the past few decades, multiple proteins in the extra-
cellular and secretory space have been found to be phos-
phorylated. Many of these phospho-proteins are secreted into
milk, serum, plasma, and cerebrospinal fluid (reviewed in (16))J. Biol. Chem. (2021) 296 100267 1
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JBC REVIEWS: The atypical Fam20 kinasesand have defined roles in diverse cellular processes from
signaling, coagulation, migration, extracellular matrix forma-
tion, proteolysis, and biomineralization. The majority of these
secreted proteins exhibit a phospho-motif of SxE/pS but to
date, we have limited knowledge of the function of the ma-
jority of these extracellular phosphorylation events (reviewed
in (16)). Interestingly, out of the 540 kinases in the human
kinome, only two kinases have been found localized in the
secretory pathway: protein O-mannosyl kinase (POMK/
SGK196) (17, 18) and the tyrosine kinase, vertebrate lonesome
kinase (VLK/SGK493) (19), both of which do not phosphory-
late SxE/pS motifs. Because the identity of the kinase(s)
responsible for the majority of extracellular phosphorylation
events remained elusive, the study of extracellular phosphor-
ylation has lagged behind that of intracellular phosphorylation.
It is increasingly clear that extracellular phosphorylation
events play just as important roles in cellular regulation as
their intracellular counterparts.
To date, there are 13 known secretory pathway kinases (or
kinase-like proteins), and we know very little about some of
them. In a handful of cases, we do not know their substrate
specificity or even if they are active kinases. This review fo-
cuses on Fam20A, B, C, the small subfamily of secretory
pathway kinases for which we have made significant progress.
In particular, we will address their cellular functions, reported
substrates, structure/function relationships, and importance in
human disease.
Secreted kinases
VLK family and POMK
VLK and POMK are two secreted kinases that can be found
at the root of the kinome tree. Therefore, their amino acid
sequences were well enough conserved with the canonical
kinases for them to be classified as kinases. POMK is an O-
mannose kinase important for dystroglycan receptor function
and matriglycan elongation (18, 20). VLK is the first secreted
tyrosine kinase identified, and it phosphorylates a broad range
of secreted and ER-resident substrates (19). A PSI-BLAST
search using VLK as a query produces another small family
of potential secreted kinases that includes Fam69A, Fam69B,
Fam69C, DIA1, and DIA1R. Very little is known about these
proteins (21–23).
Fj family of atypical kinases
As alluded to in the introduction, the study of extracellular
kinases was spearheaded by Ken Irvine’s laboratory when they
published the first example of a secreted kinase, the fly protein
Fj, which they went on to show phosphorylated unusual cad-
herin domains (12). The murine equivalent of Fj, four-jointed
box 1 (FJX1) is involved in forming appropriate dendrite arbor
morphology in the hippocampus (24), and recently, human
FJX1 has been shown to increase the invasive potential of
nasopharyngeal cancer cells (25, 26). In addition to FJX1 and
Fam20A, B, and C, this small family contains two additional2 J. Biol. Chem. (2021) 296 100267members, Fam198A and Fam198B. To date, neither Fam198A
nor B has been ascribed kinase activity, and very little is known
about their cellular functions (27, 28).Fam20B, the secreted xylose kinase
Vertebrates exhibit three members of the Fam20 family of
proteins (Fam20A,B, and C), whereas early invertebrates such
as hydra and sponge have a single homolog of Fam20 whose
activity resembles the human Fam20B-like protein (Fig. 1) (29).
Within the Fam20 family of secretory kinases, Fam20B was
identified as a xylosylkinase kinase that phosphorylates xylose
residues within the conserved tetrasaccharide linkages of pro-
teoglycans (15). Interestingly, the xylose phosphorylation on the
proteoglycan tetrasaccharide linkage was first identified in hy-
dra (30), and further biochemical investigation revealed that
hydra Fam20 and sponge Fam20 lacked protein kinase activity
but exhibited robust xylosylkinase activity (29). In fact, Fam20B
is thought to be the first ancestral template protein for the
Fam20 family of kinases and the function of xylose phosphor-
ylation is conserved through the animal phylum from sponges
to humans (29). This evolutionary relationship is apparent in
available structures. The ATP-binding sites of Fam20B and
Fam20C are highly conserved (Fig. 2, A and B). However,
Fam20B has a unique saccharide binding site not present in
Fam20C or Fam20A (Fig. 2, A and C) (29). Fam20C homologs
are characterized by an occluded substrate binding pocket that
cannot accommodate bulky saccharide substrate due to steric
clashes. This occlusion results from slight structural rear-
rangements arising from distal residue substitutions that posi-
tion a flexible loop within the binding pocket (Fig. 2D) (29). The
Fam20B-mediated xylose phosphorylation robustly stimulates
galactosyltransferase II (GalT-II) activity leading to further
addition of galactose to the tetrasaccharide linkages and
accelerated proteoglycan chain extension (Fig. 5) (14).
Furthermore, EXTL2 (Exostosin-Like Glycosyltransferase 2)
polymerase utilizes the xylose phosphorylation to transfer a
GlcNAc residue to the tetrasaccharide linkage region leading to
termination of proteoglycan chain elongation (31). Intriguingly,
depletion of Fam20B leads to immature proteoglycan forma-
tion, a phenotype quite reminiscent of Ehlers–Danlos syn-
drome, a rare inherited condition that affects connective tissue
owing to GalT-II mutations (14). Thus, Fam20B plays an
evolutionarily conserved quality-control role for proteoglycan
biosynthesis and is arguably the ancestral Fam20.
Whole-body genetic depletion of Fam20B in mice was em-
bryonic lethal at E13.5 with the embryos exhibiting severe
development defects and significant organ hypoplasia (32).
These observations were consistent with studies in zebrafish
wherein loss-of-function mutants of Fam20B led to aberrant
cartilage matrix organization and early stages of chondrocyte
hypertrophy leading to skeletal defects (33). These initial
in vivo observations were further echoed when tissue-specific
depletion of Fam20B in mice led to the development of su-
pernumerary teeth (34, 35), chondrosarcoma with major
Figure 1. Fam20 is conserved in animal kingdom. Fam20B glycan kinase is the ancestral Fam20 kinase with a conserved role across the entire animal
kingdom (nematode exception). Fam20C is first observed in nematodes with gene duplications observed in some organisms. In mammals only one copy of
Fam20C is observed. Fam20A is observed in vertebrates only. (UniProt/UniParc accession IDs are provided).
JBC REVIEWS: The atypical Fam20 kinasespostnatal ossification defects (36), and severe craniofacial de-
fects (37). Thus, the overarching role of Fam20B in proteo-
glycan biosynthesis likely contributes to the skeletal and
developmental defects observed upon Fam20B depletion in
tissue-specific in vivo models. In humans, two lethal com-
pound heterozygous variants in Fam20B have been identified
in a girl who died soon after birth (Fig. 2E) (38). The genetic
alterations reported were T59Afs and N347Mfs and the pa-
tient exhibited severe organ hypoplasia, skeletal defects, and
respiratory failure (38). The amino terminal T59A frameshift
leads to hypomorphic gene function and essential loss of one
allele of Fam20B. The carboxy-terminal alteration, N347M
frameshift, results in disruption of more than 15% of the
protein sequence and results in the loss of C389, which forms a
disulfide bond with C332 and likely contributes to the global
stability of the protein. The N347M frameshift, therefore, re-
sults in a destabilized Fam20B and also represents a func-
tionally inactive variant. Intriguingly, osteoarthiritis and
osteochondropathy patients with decreased proteoglycans and
chondrocyte numbers exhibited marked reduction of Fam20B,
GalT-II, and EXTL2 protein levels in knee cartilage biopsy
samples (39). This suggests that Fam20B could be a predictive
marker for specific bone diseases.Fam20C, the secreted Golgi casein kinase
As stated previously, the story of milk casein as a phos-
phoprotein started in the late 19th century when OlofHammarsten reported the presence of phosphorus in casein
(1). Fifty years later, Fritz Lipmann identified that the phos-
phorus was covalently bound to casein as phosphoseryl groups
(40). Eventually, the sequences surrounding those phospho-
seryl groups in casein were identified as SxE/pS, which
prompted the idea that SxE/pS sequence was the preferential
motif for enzymes phosphorylating casein (41, 42) within the
secretory pathway (43). In subsequent years, two cytoplasmic
kinases were shown to robustly phosphorylate casein in vitro
and because of this ability were designated casein kinase 1 and
2 (44). This was despite the fact that they would never come
into contact with casein because they were localized to the
cytoplasm and nucleus while casein, a secreted protein, resided
in the secretory pathway and extracellularly. The bona fide
“Golgi casein kinase” activity was initially observed in lactating
mammary glands (41, 43, 45) and partially purified from milk
(46). Lorenzo Pinna and colleagues extensively characterized
the activity of the partially purified protein from Golgi frac-
tions and further reported that the kinase was highly resistant
to the majority of the well-established kinase inhibitors
including staurosporine (3, 47–50). In 2012, this elusive ac-
tivity was identified molecularly when Fam20C was experi-
mentally recognized to be the Golgi casein kinase capable of
phosphorylating casein in vivo (11). Although atypical, crys-
tallography studies on the nematode-ortholog of Fam20C (51)
revealed that the kinase exhibited the canonical N- and C-
lobed kinase structure with a well-defined ATP-binding active-
site pocket (Fig. 3A). The breadth of Fam20C’s activity wasJ. Biol. Chem. (2021) 296 100267 3
Figure 2. Structure of FAM20B, the glycan kinase. A, structure of Hydra magnipapillata FAM20B (hmFAM20B, PDB ID: 5xoo, chain A, white) with bound
adenosine (ADN) and Galβ1-4Xylβ1 substrate. N and C lobes indicated approximately. B, FAM20B ATP-binding site (PDB ID:5xoo, chain A, white, ADN:a-
denosine) is highly conserved with C. elegans FAM20C ATP-binding site (PDB ID:4kqb, chain A, goldenrod, ADP, adenosine diphosphate). Similar residues
labeled (FAM20B:black, FAM20C:orange). C, FAM20B saccharide binding site containing Galβ1-4Xylβ1 substrate (gray) (PDB ID:5xoo, chain A). D, super-
imposed FAM20B (PDB ID:5xoo, chain A, white) with C. elegans FAM20C (PDB ID:4kqb, chain A) at saccharide binding site. Arrow indicates flexible loop
occluding saccharide binding. E, gene diagram depicting disease mutations. fs, frame shift.
JBC REVIEWS: The atypical Fam20 kinasesalluded to when phosphoproteomic studies of human plasma,
serum, and cerebrospinal fluid demonstrated that more than
two-thirds of secreted phosphorylated proteins were phos-
phorylated on SxE/pS motifs (52–54). In fact, phosphopro-
teomic analysis of secreted neuropeptides in the nervous and
endocrine system revealed that the predominant phospho-
motif was SxE (55). This was solidified by studies in which
Fam20C was ablated in several tissue culture cell lines and the
culture media was analyzed for secreted phosphoproteins (56).
Cumulatively, this work resulted in affirming that Fam20C is
the kinase responsible for phosphorylating the majority of
secreted proteins and broadened Fam20C’s substrate prefer-
ence to include phosphorylation sites other than SxE/pS sites
(56). For instance, a recent study reported that specific thre-
onine residues on the neuroendocrine chaperone 7B2 were4 J. Biol. Chem. (2021) 296 100267phosphorylated by Fam20C (57). Surprisingly, there were
nonoverlapping substrates between the secreted phosphopro-
teome from the different cell lines indicating that individual
cell populations have different milieux of secreted proteins.
Fam20C has a strong cofactor preference for Mn2+ and Co2+
ions over the canonical Mg2+ ion for its kinase activity (47)
although the physiological levels ofMg2+ in cells (around 1mM)
are 104 fold higher than Mn2+ (about 100 nM) (44). Lorenzo
Pinna and colleagues argued that under physiological circum-
stances, specific signaling components may play a role in pro-
moting Fam20C to utilize Mg2+ over Mn2+ in the secretory
pathway (44). The group reported that sphingosine and sphin-
gosine-1-phosphate significantly improved the ability of Fam20C
to utilize Mg2+ as a cofactor (50, 58). Indeed, sphingosine addi-
tion led to an eightfold higher activity of Fam20C in vitro with a
Figure 3. Structure of Fam20C, the secreted protein kinase. A, structure of C. elegans FAM20C (ceFAM20C, PDB ID:4kqb, chain A, goldenrod). N and C lobe
indicated approximately. ATP-binding site diagram of important residues. Parenthetical residues represent structurally equivalent residues in Homo sapiens
FAM20C. B, heterotetramer of Danio rerio FAM20C (drFAM20C, goldenrod) and Homo sapiens FAM20A (hFAM20A, cyan) (PDB ID:5yh2; chains A–D). Het-
erodimer interface and heterotetramer interfaces indicated. C, heterodimer of Homo sapiens Fam20C (hFAM20C, goldenrod1) and Homo sapiens FAM20A
(hFAM20A, cyan) (PDB ID:5yh3, chains A and C). Residues important to the heterodimer interface indicated. N and C lobe indicated approximately. D, gene
diagram depicting disease mutations (fs, frame shift; X, STOP/termination). E, cartoon depiction of kinase indicated positions of mutated residues when
resolved (mutations as red spheres, PDB ID:5yh3, chain C). Residue labels color coded to indicate mutation type (red: missense mutation, orange: frameshift,
and pink: STOP/termination). N and C lobes indicated approximately.
JBC REVIEWS: The atypical Fam20 kinases
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JBC REVIEWS: The atypical Fam20 kinasesthreefold increase in Vmax and a consequent threefold decrease
inKm (50, 58). However, ceramide, the precursor of sphingosine,
had no effect on Fam20C activity, thus suggesting sphingosine as
a specific activator of Fam20C (50, 58). Interestingly, the activity
of Fam20C is dynamically controlled by its binding partner
Fam20A (Fig. 3, B and C). Fam20A and Fam20C together form a
heterodimeric complex (Fig. 3C), which dramatically promotes
the activity of Fam20C to phosphorylate its substrates (13, 29).
Two heterodimers can further associate to form a hetero-
tetrameric complex (Fig. 3B), but it remains an open question as
to which form exists in vivo. This uncommon allosteric mode of
pseudokinase-mediated activation of Fam20C is further
explained below in the Fam20A section. Finally, functional an-
notations of Fam20C substrates suggest that Fam20C will play
important roles in many physiological processes and disease
states.
FAM20C substrates in nutrition and mineralization
The gene encoding casein resides on chromosome 4 sur-
rounded by other genes encoding proteins that contain mul-
tiple SxE motifs. Casein accounts for approximately 80% of the
total protein in bovine milk where it interacts with calcium
phosphate forming colloidal structures called casein micelles,
thereby providing nutrients including calcium and phosphate
for growth of bones and teeth to mammalian infants (59). The
consequences of casein phosphorylation have been intensively
studied with regard to cheese manufacturing where it is sug-
gested to affect milk technological properties by stabilizing
calcium phosphate nanoclusters and promoting micellar
growth (59–61).
In addition, chromosome 4 harbors another gene cluster
encoding the small integrin binding ligand-N-linked glyco-
proteins (SIBLINGs). These genes are known to regulate bone
and tooth development and encode osteopontin, dentin matrix
protein-1 (DMP1), matrix extracellular phosphoglycoprotein,
bone sialoprotein, and dentin sialophosphoprotein, all of
which are involved in binding calcium and all of which are
Fam20C substrates (11). In fact, Fam20C phosphorylates
DMP1 in osteoblasts and young osteoclasts, which leads to the
secretion of phospho-DMP1 into the pericanalicular matrix of
mineralized bone (62). Fam20C is further thought to indirectly
promote DMP1 transcription (63). In addition, Fam20C
phosphorylates multiple sites on osteopontin and promotes its
secretion (64) but inhibits its binding to αvβ3 integrin (65).
These negatively charged phosphorylated substrates allude to
Fam20C’s involvement in Ca2+ regulation in many varied and
diverse processes including nutrition and the formation of
mineralized tissues. Indeed, a large body of literature, focusing
on conditional tissue-specific knockout mice and cell models,
reports the roles of Fam20C in promoting biomineralization
including the growth and development of osteoblasts, osteo-
clasts, bone, dentin, and enamel (Fig. 5) (66–78).
Fam20C substrates promoting secretion and ER homeostasis
Phosphoproteomic analysis of pancreatic β -islet cells from
type 2 diabetic obese (T2D) mice revealed 39 potential6 J. Biol. Chem. (2021) 296 100267phosphosites conforming to the SxE motif (79). The study
reported that Fam20C levels went up in the cells of T2D mice,
thereby promoting secretion of immature proinsulin under
hyperglycaemic conditions (79). Upon restoring euglycaemia,
the levels of Fam20C and 11 corresponding SxE phosphosites
were brought back to basal level (79). This study suggests that
Fam20C might play an important role in the control of insulin
section from the β -islet cells of pancreas. In fact, recent
studies suggest Fam20C plays a pivotal role in ER homeostasis,
which promotes proper section, including phosphorylation of
proteins sequestered within the secretory pathway (Fig. 5).
Recent works report that Fam20C phosphorylation of ER
oxidoreductin 1α (Ero1α) on Ser145 (SxE site) is important for
regulating ER redox homeostasis and oxidative protein folding
(80). This Ero1α phosphorylation is induced following
secretion-demanding conditions such as lactation and inter-
estingly, this posttranslational event occurs in the Golgi
apparatus, and Ero1α is retrograde-transported to the ER
mediated by ERp44 (80). Furthermore, Fam20C maintains ER
proteostasis and protects against ER stress-induced cell death
(81). Protein disulfide isomerase (PDI) is a highly abundant
ER-resident enzyme playing critical roles as both a thiol-di-
sulfide oxidoreductase and a molecular chaperone, which
prevents protein misfolding in the ER (82, 83). Fam20C
phosphorylates PDI on Ser357 upon ER stress and promotes
the activity of PDI to maintain ER proteostasis (81). Indeed,
loss of Ser357 (Ser359 in mouse) leads to acute liver damage in
mice challenged with proteotoxic stress (81). Interestingly,
recent studies show that Fam20C phosphorylation is required
for the secretion of certain proteins. For example, Fam20C
phosphorylates calcium binding protein 45 kDa (Cab45), a
Golgi protein, regulating the sorting and secretion of proteins
(84). This phosphorylation regulates Cab45 oligomerization
independent of its Ca2+ binding ability and facilitates trans-
location of Cab45 into trans Golgi network-derived vesicles,
thus accelerating vesicle budding (84). Furthermore, the Cab45
phosphorylation enhances secretion of its client proteins,
including lysozyme C (84). Similarly, Fam20C phosphorylation
has been shown to be important for the secretion of osteo-
pontin (64).
Fam20C substrates in blood
Phosphoproteomic analyses of plasma and serum revealed
that the majority of phosphorylated sites identified adhered to
the SxE/pSmotif (52, 54), thus triggering the hypothesis that the
majority of the extracellular plasma/serum phosphoproteins
could be Fam20C substrates. Multiple proteins with well-
established roles in blood coagulation, phosphate homeostasis,
and complement pathways have been identified in phospho-
proteomic studies by comparing the phosphoproteome of wild-
type cells with cells lacking Fam20C (56, 85) (Fig. 5). The major
vertebrate clotting factor fibrinogen (alpha and gamma chains)
was identified as a potential substrate of Fam20C in these
phosphoproteomic screens (56). Phosphorus was found in
fibrinogen as early as 1962 and the amino acid sequence revealed
the sites to be SxE (86). During tissue and vascular injury,
JBC REVIEWS: The atypical Fam20 kinasesfibrinogen is cleaved by thrombin to fibrin peptides, which form
a fibrin-based blood clot and stop bleeding (87). It has been
reported that phosphorylated fibrinogen binds better to
thrombin, thus releasing more fibrin peptides and promoting
faster coagulation (88, 89). Fam20C has been found to directly
phosphorylate fibrinogen alpha and gamma chains in vitro (56),
and further work is needed to define the physiological roles of
the phosphorylation events. On a similar note, Fam20C phos-
phorylates the A2 domain of von Willebrand factor (vWF) on
two SxE sites, pSer1517 and pSer1613 (90). The modifications
promote platelet adhesion to sites of vascular injury and helps in
coagulation (90). Among the other serum/plasma proteins
identified as Fam20C substrates are collagen and the comple-
ment components C3 andC4 (56) wherein collagen andC3 have
been reported to be phosphorylated previously (91, 92). Further
work is needed to establish the role of Fam20C and phosphor-
ylation of its key substrates in the blood coagulation pathway.
Another well-characterized substrate of Fam20C in serum is
fibroblast growth factor-23 (FGF23), a bone-derived hormone
that regulates serum phosphate levels (85, 93). Mice with
Fam20C deletion exhibit an increase in bioactive serum FGF23
leading to the development of hypophosphatemic rickets and
skeletal defects (32, 76), which can be partially reversed by
feeding the mice a high-phosphate-containing diet (94). In fact,
within the Golgi, Fam20C phosphorylates FGF23 on Ser180
(SxE site), which inhibits its O-glycosylation and subsequently
promotes proteolysis and inactivation of the hormone (85).
Intriguingly, proteolysis-resistant missense alterations adjacent
to Ser180 (R176Q, R179W, and R179Q) activate FGF23 lead-
ing to hypophosphatemic rickets (95). Furthermore, knock-
down of Fam20C in cells promotes FGF23 mRNA expression
(63), and elevated levels of serum FGF23 contribute to car-
diovascular complications and increased mortality in patients
with chronic kidney disease (96).
Fam20C substrates in heart
Besides FGF23, which contributes directly to cardiovascular
problems in patients, various other substrates of Fam20C have
been implicated in heart disease (Fig. 5). PCSK9 (proprotein
convertase subtilisin-kexin 9) patient genetic variations
altering SxE sites correlate with LDL-cholesterol dysregula-
tion, a risk factor for heart disease (97). Importantly, Fam20C-
mediated phosphorylation of PCSK9 improves PCSK9
secretion and enhances the degradation of the low-density li-
poprotein receptor (LDLR) in endosomes/lysosomes (97). On
a similar note, PCSK7 is phosphorylated by Fam20C on Ser505
(SxE site) leading to higher triglyceride uptake into adipocytes
(98). Interestingly, exome sequencing revealed a low frequency
coding variant PCSK7, R504H, correlated with 30% lower
plasma triglyceride levels in individuals harboring this change
(98). Further biochemical analyses revealed that the R504H
substitution enhanced phosphorylation of the adjacent S505
possibly promoting higher triglyceride uptake (98).
Cardiac function, contraction and relaxation, is brought
about by a complex interplay of multiple proteins and post-
translational modifications playing essential roles in regulatingintracellular calcium (Ca2+) handling (99). The sarcoplasmic
reticulum (SR) of cardiac muscle is the Ca2+ storage organelle,
and Ca2+ is shuttled between the SR and cytosol via various SR
resident receptors during contractions and relaxations of the
heart (100). Fam20C resides in the SR of cardiac muscle and
phosphorylates multiple major Ca2+ handling machinery pro-
teins including histidine-rich Ca-binding protein (HRC),
Stim1, calsequestrin 2, sarcalumenin, triadin, calumenin, and
calreticulin (101, 102). These proteins play essential roles
mediating SR Ca2+ storage, uptake, and release (102, 103). For
example, Fam20C-mediated phosphorylation of calsequestrin
2, the major Ca2+ binding protein in the SR, dramatically alters
the ability of calsequestrin 2 to oligomerize, which is critical to
its function (102). Stim1, the luminal ER/SR Ca2+ sensor
responsible for store-operated Ca2+ entry in a variety of cell
types, is also dramatically regulated by Fam20C phosphoryla-
tion, providing the most compelling evidence of Fam20C-
mediated Ca2+ regulation. In addition, a recently discovered
Stim1-S88G substitution (within an SxE site) was found in a
patient with heart disease and the substitution, which pre-
cludes Fam20C phosphorylation, was shown to alter Ca2+
signaling (102, 104).
Interestingly, cardiomyocyte-specific Fam20C knockout
mice (cKO) exhibited signs of heart failure upon aging or
induced pressure overload by transverse aortic constriction
(102). At 9 months of age, cKO mice exhibited a significant
increase in left ventricle chamber size with distinct features of
heart fibrosis and dilated cardiomyopathy (102). The heart
failure phenotype in cKO mice is thought to be brought about
by dramatic SR Ca2+ handling defects since isolated car-
diomyocytes from aged cKO mice exhibited severe Ca2+
cycling defects and delayed relaxation (102).
Dilated cardiomyopathy (DCM) is an underlying heart
defect and is associated with sudden death in over 50% of the
cases (105). Aged cKO mice exhibit clear signs of DCM, and
although multiple substrates have been reported for Fam20C
in SR, HRC has been widely implicated in DCM (103). HRC is
an essential Ca2+ handling protein, and its depletion leads to
enhanced cardiomyocyte aftercontractions upon stress (106).
Failing human hearts exhibit lower protein levels of HRC, and
multiple genetic variants of HRC have been reported in human
DCM cases (103). Fam20C-mediated phosphorylation of HRC
is thought to control Ca2+ leak and enhance SR Ca2+ transport,
thereby maintaining ambient signaling (101). The site of
phosphorylation on human HRC is S96, which is a canonical
SxE phosphorylation site (101). Remarkably, S96A is a com-
mon human genetic variant of HRC, and patients with the
homozygous Ala/Ala variant exhibit fourfold increased risk of
lethal ventricular arrhythmias in idiopathic DCM compared
with normal Ser/Ser patients and twofold increased risk when
compared with heterozygous individuals (103). Furthermore,
preliminary genetic analysis indicates that roughly 60% of
participants had at least one copy of S96A suggesting that this
condition has extremely broad implications for heart disease
(103). The intriguing dosage-dependent manner of DCM
lethality in the nonphosphorylatable S96A genetic variant ofJ. Biol. Chem. (2021) 296 100267 7
Figure 4. Structure of Fam20A, the secreted pseudokinase. A, structure of Homo sapiens FAM20A (hFAM20A, PDB ID:5yh3, chain A, cyan). Boxes indicate
the pseudokinase active site and ATP-binding site. N and C lobes indicated approximately. B, superimposition of Homo sapiens FAM20A (hFAM20A, PDB
ID:5yh3, chain A, cyan) and C. elegans FAM20C (ceFAM20C, PDB ID:4kqb, chain A, goldenrod) active sites. Manganese coordinating residues indicated. Q258
abolishes manganese and ATP-binding. ceFAM20C ATP-binding displayed for reference. C, superimposition of Homo sapiens FAM20A (hFAM20A, PDB
ID:5yh3, chain A, cyan) and C. elegans FAM20C (ceFAM20C, PDB ID:4kqb, chain A, goldenrod) bound ATP/adenosine diphosphate (ADP). hFAM20A binds ATP
in an inverted fashion. D, gene diagram depicting disease mutations (del, deletion; fs, frame shift; X, STOP/termination). E, cartoon depiction of kinase
indicated positions of mutated residues when resolved (mutations as red spheres, PDBID:5yh3, chain C). Residue labels color coded to indicate mutation type
(red: missense mutation, orange: frameshift, pink: STOP/termination, and yellow: deletion). N and C lobes indicated approximately.
JBC REVIEWS: The atypical Fam20 kinasesHRC suggests that pS96 HRC phosphorylation by Fam20C is
likely an important molecular event in cardioprotection.
Fam20C genetic alterations in disease
Biallelic loss-of-function genetic alterations in the Fam20C
gene lead to the development of an autosomal recessive dis-
order called Raine syndrome (OMIM #259775) Figure 3D
(107–109). In 1985, two infant sisters with neonatal lethality
were reported to exhibit a unique, autosomal recessive case of
congenital sclerosing osteomalacia with cerebral calcification8 J. Biol. Chem. (2021) 296 100267(110). It was not until 2016 that their archival DNA was
sequenced to reveal a Fam20C genetic alteration in a key
conserved region (111). These patients may have been argu-
ably the first documented cases of Raine syndrome harboring
genetic alterations in Fam20C. The name “Raine syndrome”
was coined in 1989 when Raine and colleagues comprehen-
sively reported this lethal osteosclerotic bone dysplasia (112)
while links with Fam20C alterations were established by
Simpson and colleagues in 2007 (107). The cases presented
often exhibit neonatal-lethality with extreme skeletal
Figure 5. Roles of Fam20 secretory pathway kinases. The overarching roles of the Fam20 kinases identified to date are in nutrition, biomineralization,
blood, cardiac function, proteoglycan biosynthesis, allosteric kinase activation, and endoplasmic reticulum proteostasis. Fam20 paralogs are localized in the
secretory pathway and phosphorylate multiple substrates playing essential roles in animal physiology.
JBC REVIEWS: The atypical Fam20 kinasesdeformities, ectopic calcification, and organ hypoplasia (107).
Some nonlethal cases have also been reported with patients
exhibiting hypophosphatemia, altered facial and skeletal fea-
tures (108). Over 40 cases of Raine syndrome have been re-
ported worldwide and DNA sequencing revealed that all these
patients carried various alterations in the Fam20C gene, which
are likely the driving cause of disease (107–109). About 25
unique alterations have been reported for Fam20C in disease,
which affect stability, secretion, activity, and integrity of
Fam20C protein (Fig. 3D) (11, 51). Intriguingly, a direct cor-
relation has been observed between Fam20C activity and dis-
ease lethality, wherein, complete deletion leads to neonatal
lethality, whereas residual activity is sufficient to keep the in-
dividual alive beyond birth to preteen and even teenage years.
Two teenagers with hypophosphatemia and rickets exhibited a
compound heterozygous Fam20C genetic alteration where one
copy of the Fam20C gene contained a T268M substitution
(113). Fam20C T268M purified in vitro preserved only 10% of
wild-type kinase activity (50). Interestingly, FDA-approved
multiple sclerosis drug and sphingosine analog, fingolimod,
potently activated Fam20C in vitro (50). Fingolimod also led to
higher activity of Fam20C T268M in vitro (50). This suggests
that fingolimod may be utilized in partially alleviating the loss
of activity of Fam20C in nonlethal Raine syndrome patient
cases. Furthermore, a similar amino acid replacement Ser to
Thr (S410T) in a patient exhibited very mild symptoms (114).
In fact, a canine model of nonlethal Raine syndrome has been
reported exhibiting a minimally disruptive Ala to Val substi-
tution in the Fam20C kinase domain (115). Most alterations
reported alter the protein sequence of Fam20C in key
conserved regions, whereas large chromosomal rearrange-
ments (107) and splice-site alterations also result in Fam20C
deletions and disease manifestations (116, 117). The reportedFam20C disease alterations in humans with the exception of
splice-site mutations have been listed in Table 1 and Figure 3,
D and E with corresponding information on inheritance,
lethality, and effect on Fam20C protein/kinase activity.
Fam20A, the secreted pseudokinase
Unlike Fam20C, which is ubiquitously present in all tissues,
Fam20A is preferentially expressed in lactating mammary
glands and in enamel and dental matrices (13, 32). Fam20A
forms a functional heterotetrametric complex with Fam20C
(Fig. 5) and allosterically increases Fam20C activity, via het-
erodimerization, toward its substrates (Fig. 3, B and C) (13, 29).
Interestingly, formation of the heterodimer is sufficient to
allosterically increase Fam20C activity both in vitro and in
cells, and the unique contributions of the heterotetramer are
still unknown (29). Fam20A is a paralog of Fam20C and is the
first secreted pseudokinase identified (Fig. 4, A and B) (13).
Pseudokinases are proteins that share sequence homology with
kinases but lack kinase activity either due to mutations in
normally conserved amino acids that catalyze phosphoryl
transfer (118) or utilize the kinase fold to transfer molecules
other than phosphate (119, 120). A conserved Gln residue in
Fam20A replaces a Mn2+ cation coordinating Glu residue of
Fam20C, which is essential for catalysis (13). In fact, muta-
genesis studies revealed that replacing the Gln to a Glu in
Fam20A triggered hydrolysis of ATP and restored kinase ac-
tivity (13). In addition to the lack of an essential residue
required for catalysis, Fam20A binds to ATP (Fig. 4, A and C)
in a unique conformation (121). Structural studies revealed
that the ribose moiety of the ATP is “upside down,” and the
entire nucleotide is inverted with the phosphate groups
pointing at the opposite direction (121). Hence, the γ-phos-
phate is positioned away from the active site and cannot beJ. Biol. Chem. (2021) 296 100267 9
Table 1
Fam20C genetic alterations in human disease
Amino acid Inheritance Disease Possible effect Reference
G153Rfs CH Lethal, Raine syndrome Loss of kinase domain, alters 74% of protein
sequence
(140)
S159Pfs CH Lethal, Raine syndrome Loss of kinase domain, alters 73% of protein
sequence
(140)
E166X Homo Lethal, Raine syndrome Loss of kinase domain, removes 72% of protein
sequence
(141)
W202Cfs Homo Nonlethal, mild Raine syndrome Disruption of kinase domain, alters 65% of protein
sequence
(116)
W226R Homo Nonlethal, Amelogenesis imperfecta Unknown, Possibly important for protein folding (141, 142)
I258N CH Nonlethal, severe skeletal deformities Affects Fam20C folding and secretion (11, 51, 108)
T268M CH Nonlethal, mild Raine syndrome,
hypophosphatemia
90% loss of kinase activity and reduced secretion (50, 51, 113)
G280R CH Nonlethal, severe skeletal deformities Affects Fam20C folding and secretion (11, 51, 108)
F302L CH Nonlethal, hypophosphatemic
osteomalacia with osteosclerosis
Unknown, possibly important for protein folding
and/or Fam20A/C tetramer formation
(143)
Y305X CH Nonlethal, mild Raine syndrome,
hypophosphatemia
Hypomorphic, removes 48% of protein sequence. (113)
R319K CH Lethal, multiple defects including
Raine syndrome
Unknown (144)
P328S Homo Lethal, Raine Syndrome; Nonlethal
in two siblings, severe retardation
and skeletal abnormalities
Affects Fam20C folding and secretion (11, 51, 109)
M336R Homo Lethal, Raine syndrome Affects N-glycosylation, protein folding, and secre-
tion of Fam20C
(145)
G365D Het Lethal, Raine syndrome Possible loss of function of Fam20C (111)
Y369fs CH Nonlethal, mild Raine syndrome Hypomorphic, alters 37% of protein sequence (146)
G379R Homo Lethal, Raine Syndrome Affects Fam20C folding and secretion (11, 51, 108)
G379E CH Lethal, Raine Syndrome Affects Fam20C folding and secretion (11, 51, 108)
L388R Homo Lethal, Raine Syndrome Affects Fam20C folding and secretion (11, 51, 107)
W407G Homo Nonlethal, craniofacial anomalies,
intracranial calcification,
developmental delay
Unknown, Possibly important for protein folding (147)
R408W Homo Nonlethal, mild Raine Syndrome
hypophosphatemia
Diminishes Fam20C activity to 50% (51, 148)
R409C Homo Lethal, Raine syndrome Unknown (149)
S410T Homo Nonlethal, mild skeletal issues Minimal structural disruption expected (114)
D451N Homo Lethal at preteen, Raine
Syndrome. Nonlethal cases reported




R459G CH Nonlethal, mild Raine syndrome Mutation adjacent to cation interacting Asp (146)
P496L Homo Nonlethal, mild Raine symptoms Likely disruption of Fam20C activation loop (116)
R510C CH Lethal, multiple defect, Raine syndrome Unknown (144)
R549W Homo/CH Lethal/Nonlethal, Raine Syndrome Affects Fam20C folding and secretion (11, 51, 107,
117)
R558W Homo Lethal, Raine Syndrome Unknown (150)
45, XY (7;7) (p22;p22) CH Lethal, Raine syndrome Microdeletion (107)
46, XY[hg19] 7p22.3
(36480–523731)
Homo Lethal, Raine syndrome 487 kb deletion including FAM20C (151)
CH, Compound heterozygous; fs, Frameshift; Het, Heterozygous; Homo, Homozygous; X, STOP/Termination.
Clinical presentation is heterogeneous and the classifications presented here reflect the symptomology reported in the literature.
JBC REVIEWS: The atypical Fam20 kinasesutilized for transfer. Several hydrophobic residues and
hydrogen bonds in the pseudokinase pocket bind the adenine
of ATP (Fig. 4, B and C) while the otherwise-hydrolyzable γ-
phosphate is surrounded and stabilized by extensive salt bridge
and hydrogen bonds (121). Furthermore, the “inverted” ATP-
binding to Fam20A seems to prefer the absence of metal ions
as biochemical studies indicated that the dissociation constant
of Fam20A ATP-binding is 50-fold higher in the presence of
Mn2+ cation (121). Intriguingly, ion-independent ATP-binding
of Fam20A remarkably promoted the formation and structural
homogeneity of the heterotetrameric Fam20A-Fam20C com-
plex (121). Although cation-independent ATP-binding has
been reported previously in other pseudokinases (118, 122,
123), the inverted binding to ATP and the heterotetramer
formation in the secretory pathway make Fam20A a unique
pseudokinase. Interestingly, subtle structural differences from
Fam20C redesign Fam20A’s ability to achieve kinase-
independent function (121). Fam20A has a unique and high-
ly conserved insertion in the Gly-rich loop, which triggers the10 J. Biol. Chem. (2021) 296 100267formation of two unique disulfide bonds (human Fam20A:
Cys209-Cys319 and Cys211-Cys323) (121), and truncation of
this insertion due to aberrant RNA splicing leads to the
development of tooth enamel defects called amelogenesis
imperfecta in a patient (124).
Variations in the gene encoding Fam20A result in amelo-
genesis imperfecta (AI), nephrocalcinosis (NC), and ectopic
calcification (EC) (125). Similar observations were echoed
from whole-body and tissue-specific genetic depletion of
Fam20A in mice, which exhibited clear phenotypes of AI and
dental defects (32, 126). An exhaustive list of Fam20A patient
variations with corresponding clinical information has been
reported by Nitayavardhana and colleagues in 2020 (127). To
date, about 40 different disease-causing genetic alterations
have been reported in Fam20A in 70 patients of 50 indepen-
dent families (Fig. 4D) (127). The patients exhibited nonlethal
dental symptoms including hypoplastic enamel, gingival hy-
perplasia, and unerupted permanent teeth (127). The majority
of the alterations were frameshifts with increased chances of
JBC REVIEWS: The atypical Fam20 kinaseshypomorphism, truncation, deletion, complete loss of func-
tion, major structural effects with possible dissociation from
the Fam20A–Fam20C complex. The alterations are listed in
Table 2 and Figure 4, D and E.
The roles of the Fam20 kinases in disease transcend our
current knowledge, which is evident from preliminary
studies pointing to potential roles of Fam20C in diseases
beyond biomineralization and cardiac function (36,
128–130). Developing inhibitors/activators for Fam20B or C
makes sense at this point due to their usefulness as aca-
demic tools. To date, only one inhibitor, FL-1607, has been
developed for Fam20C, and no proper in vitro target
engagement or biochemical binding/inhibitory assays have
been shown for this compound (71). It is expected that
in vivo targeting of Fam20 kinases would elicit major side
effects owing to the diverse substrates essential for organismTable 2
Fam20A genetic alterations in human disease
Amino acid Inheritance Disease
L12Afs Homo; CH AI Deletion/Hypomo
C44Afs CH AI, NC Deletion/Hypomo
A59Pfs Homo AI 29 bp duplication
R73X CH AI, NC Deletion/Hypomo
L117Cfs Homo AI, EC, NC Nonfunctional
R136X Homo AI, NC Interfere with Fam
formation, rem
L173R Homo AI, NC Impaired folding,
D197_I214delinsV CH AI Fam20C interface
L205Cfs CH AI Hypomorphic, alt
I214Nfs CH AI, NC Destabilization, in
dimer/tetramer
Q241-R271del Homo AI, NC Interferes with Fa
formation, dest
R243X CH AI, NC Destabilization, R
removes 45% o
E245Gfs CH AI, NC Interferes with Fa
alters 55% of p
F252del CH AI, NC Interferes with Fa
Y253C CH AI Destabilization, Y
with Fam20A–
R271Sfs Homo AI Destabilization, a
R276X CH AI Loss of “kinase” d
S303Cfs Homo AI, NC Destabilization, a
F305Lfs CH; Homo AI, NC Interferes with Fa
E326Gfs CH AI Destabilization, a
C330R CH AI Disruption of disu
G331D Homo AI Destabilization, in
R361C CH AI Destabilization, R
interferes with
R392Pfs Homo AI, NC Destabilizing, alte
D403N CH AI Impaired folding,
D410Pfs CH AI Destabilization, D
alters 24% of p
F417Vfs CH AI Destabilization, a
A432T CH AI Destabilization, la
G436E Homo AI Interferes with sa
S450Pfs Homo AI, NC Destabilization, a
17% of protein
K457X Homo AI, NC Destabilization, re
R478X CH; Homo AI, NC Destabilization, R
removes 11% o
E483Kfs Homo AI, NC, EC Destabilization, a
H494fs CH AI, NC, EC Destabilizing, alte
L495Tfs Homo AI, NC, EC Destabilizing, alte
L495Nfs Homo AI, NC Destabilizing, alte
I505Sfs Homo AI, NC Destabilizing, I50
interactions, alt
T508Kfs Homo AI Destabilizing, T50
alters 6% of pro
54.7kb duplication CH AI Unknown.
AI, Amelogenesis imperfecta; CH, Compound heterozygous; del, deletion; delins, deletion
Homozygous; NC, nephrocalcinosis; X, STOP/Termination.
Clinical presentation is heterogeneous and the classifications presented here reflect the sfunction (11, 56). The following section provides the
evolutionary perspective of the Fam20 family from early
invertebrates to mammals.
Fam20 and animal evolution
Fam20 orthologues are observed across the animal kingdom
from sponge to mammals and early invertebrates have a single
copy of the Fam20 gene (Fig. 1) (29). Amphimedon queens-
landica or sponge is considered to be the oldest animal
phylum (131) and exhibits a single copy of the Fam20 gene,
which has Fam20B-like glycan kinase activity and produces
phosphorylated xylose residues on tetrasaccharide linkers (29).
Cnidarians such as Hydra magnipapillata also exhibit a single
Fam20B-like protein (29), which robustly phosphorylates
xylose residues and is thought to contribute to CS peptido-
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and insertion; EC, Ectopic calcification; fs, Frameshift; Het, Heterozygous; Homo,
ymptomology reported in the literature.
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JBC REVIEWS: The atypical Fam20 kinasesmammals (30). An interesting exception is the nematode
Caenorhabditis elegans (C. elegans) as it is, to date, the only
organism known that does not have a Fam20B-like kinase
activity (51). Even though proteoglycan biosynthesis in
C. elegans is remarkably conserved when compared with that
in humans, only unphosphorylated xylose is detected in the
tetrasaccharide linker of C. elegans CS proteogylcans (132),
highlighting the absence of Fam20B activity (51). Instead,
Fam20 in C. elegans (known as FAMK-1) is a protein kinase
with the same SxE substrate preference as mammalian
Fam20C (51, 133). A study of FAMK-1 in C. elegans to un-
cover its ancestral roles revealed that it is involved in many
physiological processes contributing to fertility, embryogen-
esis, and development (133). During embryogenesis, FAMK-1
prevents multinucleation, which can be overcome by elevating
the temperature or lowering cortical stiffness (133). In adults,
FAMK-1 expression in the spermatheca, a tissue that un-
dergoes repeated mechanical strain controlled by calcium
fluxes, is important for fertility (133). In the context of the
organism, it is clear that Fam20C activity is required in the late
secretory pathway or outside the cell for function (133).
The advent of twomembers in Fam20 family is first observed in
arthropods (29). Drosophila melanogaster has one copy each of
Fam20B and Fam20C (29). In fact, Fam20C phosphorylates
Drosophila egg yolk proteins in vitro (5), which are the closest
functional analogs of vitellogenin and phosvitin (134). As stated
previously, phosvitin, one of the most heavily phosphorylated
proteins known, is a Fam20C substrate (5). Phosvitin is cleaved
from vitellogenin, the major egg yolk protein found in all egg-
laying animals (4), and largely consists of long stretches of
serine residues that are phosphorylated by Fam20C despite the
absence of glutamate residues (5). Phosphorylation of vitellogenin
and/or its phosvitin domains occurs in birds, fish, worm, and in-
sect yolk proteins (5),making this awidespread and evolutionarily
conserved modification. It is duly noted that the functional con-
sequences of these phosphorylation events have yet to be deter-
mined. Fam20C also plays important roles in Apis sp. or the
honeybeewhere it phosphorylates royal jellyproteins (135).An in-
depthphosphoproteomics studyof royal jelly proteinsdetermined
that they are phosphorylated mainly on SxE sites likely by a
Fam20C-like protein in the hypopharyngeal and mandibular
glands of nurse bees fromwhere royal jelly is secreted (135). Royal
jelly is an indispensable dietary component of the queen bee and
possesses antibacterial, anticancer, antihypertensive, and anti-
oxidative effects that coincidentally benefit human health
(135–137). Significantly, the antimicrobial activities of royal jelly
are influenced by phosphorylation in complex ways (135).
While the role of Fam20C in biomineralization in vertebrates
is well documented, the study of Fam20’s role in invertebrate
biomineralization is in its infancy. A recent study characterized
Fam20 cDNA from the pearl oyster, Pinctada fucata, and
determined that it was expressed in the mantle edge positioned
to play a role in shell formation (138). Furthermore, its
expression increases in the stage of development when the shell
is first forming and knockdown of Fam20 in vivo by RNA
interference resulted in the formation of abnormal calcium
carbonate crystals during shell formation (138). It is intriguing12 J. Biol. Chem. (2021) 296 100267that Fam20C could be involved in calcium carbonate as well as
calcium phosphate biomineralization processes, nevertheless it
remains to be shown that P. fucata Fam20 displays Fam20C
kinase activity on relevant substrates. Echinoderms such as
Strongylocentrotus purpuratus or sea urchins exhibit a dupli-
cation of Fam20C wherein it has one copy of Fam20B and 2
copies of the Fam20C genes (29). Protochordates such as
Branchiostoma and Saccoglossus exhibit both Fam20B and
Fam20C; however, the tunicates such as Ciona intestinalis and
Oikopleura dioica seem to have a single Fam20 gene exhibiting
Fam20B-like functions (29). The reason is unclear; however,
incomplete genome sequencing could be a contributing factor
for this “absence” (29).
Fam20A is first observed in fish (139). In fact, fish express
three copies of Fam20C and one copy each of Fam20B and
Fam20A (29). Vertebrates have all three members of this sub-
family, Fam20A, B, and C, while invertebrates/protochordates
do not possess a Fam20A orthologue. This may be attributable
to the need for enhanced Fam20C activity, which presumably
would promote biomineralization necessary for the formation
of bones and tooth enamel. It is a mystery why divergent animal
species have maintained different Fam20 protein activities, but
as pointed to previously, these phylogenetic analyses demon-
strate that the Fam20B glycan kinase is likely the ancestral ki-
nase (29). Fam20Amay have been derived from Fam20C, lost its
kinase activity but gained the function of activating Fam20C as a
pseudokinase partner in vertebrates (29).Concluding remarks
Since 1883, secreted proteins have been known to be
phosphorylated. The identification of Fam20C in 2012 dis-
placed the intracellular CKs as genuine casein kinases and
opened up a new field wherein over 100 substrates across the
phosphoproteome were linked to a single secreted atypical
kinase (11, 56). With a preferred motif of SxE/pS, Fam20C can
account for approximately two-thirds of the secreted phos-
phoproteome. But, a large fraction of secretory phosphopro-
teins exhibits pThr, non-SxE pSer, and pTyr phosphorylation
events, which may not be attributable to Fam20C. The field of
secretory pathway and extracellular phosphorylation is poised
to expand rapidly with the continued characterization of the
kinases that function in these environments. Most of the
secretory pathway kinases’ activities and functions have yet to
be elucidated. It is unknown whether the other FJX and VLK
family proteins are kinases and if so whether their substrates
are proteins, lipids, or metabolites. On the other hand, we have
made significant progress with the subfamily of secreted ki-
nases composed of actual kinases, Fam20B and C and the
pseudokinase Fam20A (Fig. 5). With established links to hu-
man skeletal diseases, the initial roles of the Fam20 family were
thought to be focused on biomineralization; however, identi-
fication of SxE/pS motifs in over two-thirds of all secreted
phosphoproteome including plasma, serum, cerebrospinal
fluid, neuropeptides, and extracellular matrix components
points to a diverse function of Fam20C. Indeed, our work with
the heart-specific Fam20C knockout mouse revealed the
JBC REVIEWS: The atypical Fam20 kinasesquintessential role of Fam20C in maintaining cardiac health
(101, 102). Furthermore, roles of Fam20B and Fam20C in
invertebrate organisms suggest roles in glycan function,
mollusk shell formation, insect egg development, beehive
nutrition, and fertility of nematodes. Other groups have also
reported diverse substrates for Fam20C playing essential roles
in endoplasmic reticulum homeostasis, coagulation, nutrition,
and hormonal regulations. Thus, organ-specific focus on
Fam20C should reveal further systematic functions of Fam20C
modulating a diverse set of substrates. Indeed, activators of
Fam20C may benefit nonlethal Raine patients as well as pro-
tect against heart disease and other potential systemic health
issues. Thus, the roles of the Fam20 family extend far beyond
biomineralization, and greater focus should be put on identi-
fying these multiple roles in diverse systems. We believe that
the Fam20 family is just the tip of the iceberg since multiple
secretory pathway kinases remain enigmatic. In fact, recent
studies have revealed that the kinome possibly expands far
beyond the 540 kinases with predicted kinases and pseudoki-
nases exhibiting diverse functions beyond phosphate transfer
(119, 120). Identification of the Fam20 family is a testament to
the fact that atypical kinases exhibit catalytic residues, struc-
tural features, and cellular localizations outside of conven-
tional knowledge. Hence, we have just scratched the surface of
the physiological significance of extracellular phosphorylation
and many exciting prospects await the field for the near future.
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